What is Modulo Bio?
Modulo Bio, headquartered in San Diego, California, is a biotechnology firm specializing in the intricate workings of the nervous system. The company's focus on neurological research and development positions it at the forefront of addressing complex medical challenges. This strategic backing will likely fuel further advancements in their therapeutic pipeline and research initiatives, aiming to translate scientific discoveries into tangible patient benefits.
How much funding has Modulo Bio raised?
Modulo Bio has raised a total of $8M across 1 funding round:
Other Financing Round
$8M
Other Financing Round (2023): $8M with participation from Bioverge, Initialized Capital, and Builders VC
Key Investors in Modulo Bio
Bioverge
Bioverge is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life. The firm's investment thesis spans the intersection of Health + Tech and has built a portfolio of 23 companies.
Initialized Capital
Initialized Capital is a venture capital firm dedicated to supporting seed stage founders across various sectors including enterprise SaaS, sustainability, health, hard tech, artificial intelligence, infrastructure, consumer, and crypto. They focus on providing the necessary tools and guidance for entrepreneurs from the early stages to long-term success.
Builders VC
Builders VC is a venture capital firm focused on modernizing antiquated industries by investing in innovative technologies and solutions. They support founders who tackle complex problems and aim to reshape systems across various sectors, including construction, healthcare, and agriculture.
What's next for Modulo Bio?
With this substantial infusion of capital, Modulo Bio is poised for accelerated growth and innovation. The enterprise-level funding suggests a strategic focus on expanding its research capabilities, potentially initiating clinical trials, and scaling its operational infrastructure. The company's trajectory indicates a strong commitment to advancing neurological treatments and solidifying its market position in the competitive biotechnology landscape.
See full Modulo Bio company page
